Management of ABO-incompatible living-donor liver transplantation: Past and present trends

Surgery Today

Volumn 41, Issue 3, 2011, Pages 317-322

  Raut, Vikram ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Living donor liver transplantation; Rituximab

Indexed keywords

GABEXATE MESILATE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PROSTAGLANDIN E1; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ACUTE GRAFT REJECTION; ANTIBODY TITER; ARTERY THROMBOSIS; B LYMPHOCYTE; BILE LEAKAGE; BLOOD GROUP ABO INCOMPATIBILITY; CHOLANGITIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COST; DRUG MEGADOSE; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE DEPLETION; NONHUMAN; OUTCOME ASSESSMENT; PLASMAPHERESIS; REVIEW; SINGLE DRUG DOSE; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; HUMANS; IMMUNOLOGIC FACTORS; LIVER TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS;

EID: 79955934969     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4437-3     Document Type: Review

References (30)

1. Yoshimura N, Okajima H, Ushigome H, Sakamoto S, Fujiki M, Okamoto M. Current status of organ transplantation in Japan and worldwide. Surg Today 2010;40(6):514-25.
2. Starzl TE. Experience in hepatic transplantation. Philadelphia: Saunders; 1969.
3. Starzl TE, Koep LJ, Halgrimson CG, Hood J, Schroter GP, Porter KA, et al. Fifteen years of clinical transplantation. Gastroenterology 1979;77(2):375-88.
4. Gordon RD, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE. Liver transplantation across ABO blood groups. Surgery 1986;100(2):342-8. (Pubitemid 16037556)
5. Rego J, Prevost F, Rumeau JL, Modesto A, Fourtanier G, Durand D, et al. Hyperacute rejection after ABO-incompatible orthotopic liver transplantation. Transplant Proc 1987;19(6):4589-90. (Pubitemid 18049670)
6. Gugenheim J, Samuel D, Fabiani B, Saliba F, Castaing D, Reynes M, et al. Rejection of ABO incompatible liver allografts in man. Transplant Proc 1989;21(1 Pt 2):2223-4. (Pubitemid 19131196)
7. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336(8714):519-23. (Pubitemid 20278096)
8. Sanchez-Urdazpal L, Sterioff S, Janes C, Schwerman L, Rosen C, Krom RA. Increased bile duct complications in ABO incompatible liver transplant recipients. Transplant Proc 1991;23(1 Pt 2):1440-1.
9. Tokunaga Y, Tanaka K, Fujita S, Yamaguchi T, Sawada H, Kato H, et al. Living related liver transplantation across ABO blood groups with FK506 and OKT3. Transpl Int 1993;6(6):313-8. (Pubitemid 23325250)
10. Renard TH, Andrews WS. An approach to ABO-incompatible liver transplantation in children. Transplantation 1992;53(1):116-21.
11. Dunn SP, Halligan GE, Billmire DF, Vinocur CD, Lawrence J, Falkenstein K, et al. ABO-incompatible liver transplantation: a risk worth taking. Transplant Proc 1993;25(6):3109. (Pubitemid 24007245)
12. Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988;132(3):489-502.
13. Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73(12):1959-61. (Pubitemid 34701009)
14. Taenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I, et al. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med 1983;11(9):735-8. (Pubitemid 13001253)
15. Nakamura Y, Matsuno N, Iwamoto H, Yokoyama T, Kuzuoka K, Kihara Y, et al. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report. Transplant Proc 2004;36(8):2269-73. (Pubitemid 39555500)
16. Monteiro I, McLoughlin LM, Fisher A, de la Torre AN, Koneru B. Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation. Transplantation 2003;76(11):1648-9. (Pubitemid 37549847)
17. Kawagishi N, Satoh K, Enomoto Y, Akamatsu Y, Sekiguchi S, Fukumori T, et al. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Transplant Proc 2005;37(2):1205-6. (Pubitemid 40590837)
18. Usuda M, Fujimori K, Koyamada N, Fukumori T, Sekiguchi S, Kawagishi N, et al. Successful use of anti-CD20 monoclonal anti-body (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 2005;79(1):12-6. (Pubitemid 40139994)
19. Troisi R, Noens L, Montalti R, Ricciardi S, Philippe J, Praet M, et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006;12(9):1412-7. (Pubitemid 44405131)
20. Yamada Y, Hoshino K, Morikawa Y, Okamura J, Hotta R, Komori K, et al. Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia. J Pediatr Surg 2006;41(12):1976-9. (Pubitemid 44854959)
21. Morioka D, Togo S, Kumamoto T, Takeda K, Matsuo K, Inayama Y, et al. Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejection. Transplantation 2008;85(2):171-8. (Pubitemid 351156846)
22. Kim BW, Park YK, Kim YB, Wang HJ, Kim MW. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea. Transplant Proc 2008;40(10):3772-7.
23. Testa G, Vidanovic V, Chejfec G, Gangemi A, Iqpal R, Porubsky M, et al. Adult living-donor liver transplantation with ABO-incompatible grafts. Transplantation 2008;85(5):681-6. (Pubitemid 351398243)
24. Matsuno N, Iwamoto H, Nakamura Y, Hama K, Kihara Y, Konno O, et al. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma. Transplant Proc 2008;40(8):2497-500.
25. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008;47(1):143-52. (Pubitemid 351171051)
26. Kozaki K, Egawa H, Ueda M, Oike F, Yoshizawa A, Fukatsu A, et al. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience. Ther Apher Dial 2006;10(5):441-8. (Pubitemid 44652206)
27. Llende M, Santiago-Delpin EA, Lavergne J. Immunobiological consequences of splenectomy: a review. J Surg Res 1986;40(1):85-94. (Pubitemid 16212666)
28. Yoshizawa A, Sakamoto S, Ogawa K, Kasahara M, Uryuhara K, Oike F, et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 2005;37(4):1718-9. (Pubitemid 40790808)
29. Genberg H, Hansson A, Wernerson A, Wennberg L, Tyden G. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006;6(10):2418-28. (Pubitemid 44359429)
30. Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009;88(3):303-7.